A study in Lancet Regional Health: Southeast Asia, led by Anoop Misra, indicates that HbA1c tests for Type 2 diabetes (T2D) may be unreliable in South Asia, especially India.
High prevalence of anaemia, haemoglobinopathies like sickle cell disease and thalassaemia, and G6PD deficiency can distort HbA1c results.
Sole reliance on HbA1c may delay diagnosis by up to four years in men with undetected G6PD deficiency, increasing complication risks.
The study suggests a multiparametric approach integrating oral glucose tolerance test, self-monitoring of blood glucose, and continuous glucose monitoring for accurate diagnosis.
Detailed Insights:
HbA1c, a common diagnostic tool for T2D, measures glycated haemoglobin levels to estimate average blood glucose over 2-3 months.
Conditions affecting haemoglobin quantity, structure, or lifespan, such as anaemia and haemoglobinopathies, can distort HbA1c values, leading to inaccurate blood glucose estimations.
Poorly standardized HbA1c assay methods further complicate the interpretation of HbA1c values, especially in resource-limited settings.
In regions with nutritional challenges and iron-deficiency anaemia, HbA1c readings can be significantly distorted, affecting both diagnosis and monitoring of diabetes.
A multiparametric approach, including oral glucose tolerance tests and continuous glucose monitoring, is essential for accurate diagnosis and treatment decisions, particularly in primary care.
In Type 1 diabetes, a non-linear relationship between mean blood glucose and HbA1c has been observed, further complicating the use of HbA1c as a reliable marker.
Key Concepts Involved:
HbA1c: Glycated haemoglobin, a measure of average blood glucose levels over 2-3 months.
Anaemia: A condition characterized by a deficiency of red blood cells or haemoglobin in the blood.
Haemoglobinopathies: Genetic disorders affecting the structure or production of haemoglobin.
G6PD Deficiency: A genetic disorder that affects red blood cells, potentially leading to anaemia.